Featured In OB/GYN
Researchers at Mass General are studying the effects of SARS-CoV-2 infection and mRNA vaccines in pregnant and lactating individuals, as well as neonates.
Featured In Research and Innovation
A Phase 3 clinical trial conducted by Massachusetts General Hospital researchers and an international team of colleagues has led to the FDA's approval of an oral drug for treatment of adults with pyruvate kinase deficiency, a rare red blood cell disorder.
Featured In Neuroscience
Clinician-researchers at the Center for Precision Psychiatry at Massachusetts General Hospital with colleagues at Harvard University, Harvard Medical School and Boston Children's Hospital have developed an algorithm to improve the prediction of suicide risk in clinical settings.
The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.
We are seeking individuals who self-identify as having high stress to participate in a randomized study using a mindfulness-based, stress-reduction intervention and PET-MR imaging.